Judith Feucht receives Life Sciences Bridge Award 2025
🎉Congratulations to our member Judith Feucht on receiving the 🏆 Life Sciences Bridge Award 2025 – one of the most highly endowed awards for early-career scientists in Germany worth 💶100,000 euros.
🔬Judith’s research is dedicated to advancing CAR-T cell therapies 🧬, which hold the potential to revolutionize cancer treatment. 💉While conventional T cells rely on cancer cells presenting antigens via MHC-I molecules, CAR-T cells bypass this mechanism by being 🧪 genetically modified and equipped in the lab with an antibody-like receptor. This enables them to recognize and attack cancer cells directly.
👩🔬During her postdoctoral fellowship at the Memorial Sloan Kettering Cancer Center in 🗽New York, Judith developed a CAR variant that significantly improved the efficacy and tolerability of CAR-T cell therapies in preclinical trials. First clinical trials now show that these CAR-T cells are ⏳longer-lasting, more effective, and better tolerated than conventional CARs. This breakthrough paves the way not only for treatments against blood cancers but could also be helpful in treating solid tumors such as breast cancer or mesothelioma.
✈️Since returning to Tübingen, Judith has been conducting research as Clinician Scientst within our Cluster at the Eberhard Karls Universität Tübingen and is working as a pediatrician at Universitätsklinikum Tübingen. Beyond her scientific contributions, she is a dedicated mentor supporting young female scientists and actively advocates for better reconciliation of family and career 👩👧👩🔬.
🤩We are proud that Judith is part of our cluster and is helping to shape the future of cancer research!
👏Congratulations, Judith, on this well-deserved recognition! 🌟
🏆The Life Sciences Bridge Award is granted by the Aventis Foundation – an independent, nonprofit organization based in Frankfurt. The foundation is committed to supporting science, research, education, and culture, thereby fostering innovation and progress across disciplines.
📸Uwe Dettmar